Mode
Text Size
Log in / Sign up

alpha-lipoic acid

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of alpha-lipoic acid

7 trials tracked of alpha-lipoic acid: 2 in phase 3 or 4.

7Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 3 Other / NA 2
  1. Phase 4 Alpha Lipoic Acid for Treatment of Diabetic Neuropathy Completed
  2. Phase 3 Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin Completed
  3. Phase 2 Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy Completed
  4. Phase 2 Alpha Lipoic Acid in Geographic Atrophy Completed
  5. Phase 2 Provision of Antioxidant Therapy in Hemodialysis (PATH) Study Completed
  6. N/A Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance Completed
Show 1 more trials
  1. N/A Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.